Literature DB >> 1898987

Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.

J Erikson1, M Z Radic, S A Camper, R R Hardy, C Carmack, M Weigert.   

Abstract

Self-reactive B cells can be regulated by either deletion or inactivation. These manifestations of self-tolerance have been dramatically shown in transgenic mice in which the number of self-reactive cells has been artificially expanded. We have now extended these models to ask if B-cell tolerance as described for non-disease-associated antigens also operates for the targets of autoimmunity. The target we have chosen is DNA. Anti-DNA antibodies are diagnostic of certain autoimmune syndromes in humans and are a characteristic of the murine model of systemic autoimmunity, the MRl/lpr mouse. Antibodies to both single-stranded and double-stranded DNA have been implicated in disease. By generating anti-DNA transgenic mice, we have addressed the question of whether DNA-specific B cells are regulated in normal (non-autoimmune) mice. We indeed found that most transgenic B cells bind DNA, yet we failed to detect secreted anti-DNA. We suggest that as a consequence of their self-reactivity these B cells are developmentally arrested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898987     DOI: 10.1038/349331a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  155 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition.

Authors:  J Lang; D Nemazee
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

3.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

Review 4.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 5.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

Review 6.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

7.  Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

Authors:  S Hirose; K Yan; M Abe; Y Jiang; Y Hamano; H Tsurui; T Shirai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

8.  Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.

Authors:  Corey Tan; James L Mueller; Mark Noviski; John Huizar; Denise Lau; Alexandra Dubinin; Ari Molofsky; Patrick C Wilson; Julie Zikherman
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

9.  Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.

Authors:  Laurent Verkoczy; Marilyn Diaz; T Matt Holl; Ying-Bin Ouyang; Hilary Bouton-Verville; S Munir Alam; Hua-Xin Liao; Garnett Kelsoe; Barton F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  Increasing the chemical potential of the germ-line antibody repertoire.

Authors:  N Sarvetnick; D Gurushanthaiah; N Han; J Prudent; P Schultz; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.